Coalition urges changes in controlled-substance prescribing

A group of IT and pharma-related companies has begun lobbying for changes in the rules around controlled drugs which would allow physicians to prescribe them electronically. Members of the group, the Controlled Substances Coalition, include BlueCross Blue Shield, CVS, the American Society of Consultant Pharmacists, Wal-Mart and Sage Software.

At present, the companies say, many doctors cite the requirement to write paper prescriptions for controlled substances as the main reason they aren't converting all their scripts to digital form. Physicians and pharmacists say that they're reluctant to switch to e-prescribing if they're going to have to maintain both a paper and an electronic process for prescription management. Group leaders, who testified in a Congressional hearing yesterday, are calling on the Drug Enforcement Administration (DEA) to change its policies in this regard. The DEA seems reluctant to do so, however, arguing that non-paper methods may not be secure.

To find out more about the debate:
- read this Healthcare Finance News article

Related Articles:
Groups launch campaign to promote e-prescribing. Report
E-prescribing: What's holding it back? Editorial
Mississippi Medicaid saves $14M with e-prescribing. Report
Ohio health system rolls out e-prescribing. Report
NH governor backs e-prescribing. Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.